Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-19

FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved a supplemental application for Baraclude (entecavir) by E.R. Squibb & Sons, L.L.C. The approval updates the product labeling to reflect the approve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baraclude (entecavir)

Snippet

SUPPL AP for BARACLUDE (ENTECAVIR)